Literature DB >> 28085174

Mannose receptor as a potential biomarker for gastric cancer: a pilot study.

Deng-Rui Liu1, Quan-Lin Guan1, Ming-Tai Gao1, Lei Jiang1, Hong-Xia Kang1.   

Abstract

BACKGROUND: The mannose receptor is an immune adhesion molecule mainly expressed on the surface of antigen-presenting cells such as nonmature dendritic cells and macrophages. This study aimed to investigate mannose receptor expression and its predictive role in papillary gastric cancer patients.
METHODS: The expression of the mannose receptor was measured in 120 samples of gastric cancer tissues and corresponding paracarcinoma tissues, by immunohistochemical and quantitative real-time PCR analysis. The relationships between mannose receptor expression and clinicopathological features of gastric cancer patients were analyzed.
RESULTS: The expression rate of the mannose receptor in gastric cancer cells was 45.8% (54/120), significantly higher than that in the paracarcinoma tissue (20.0%, 36/120) (χ2 = 6.286, p = 0.012). High expression of the mannose receptor was closely related to tumor size, T stage, N stage and Union for International Cancer Control (UICC) stage of gastric cancer (p<0.05). A Kaplan-Meier survival model indicated that the survival of patients in the high-expression mannose receptor group was significantly shorter than in the low-expression mannose receptor group (p<0.05). Cox regression analysis showed that high mannose receptor expression was an independent predictor for the prognosis of patients with gastric cancer.
CONCLUSIONS: High mannose receptor expression indicates poor prognosis for gastric cancer patients. The mannose receptor may be an important molecular marker for gastric cancer prognosis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28085174     DOI: 10.5301/jbm.5000244

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   2.659


  7 in total

1.  Regiochemical Effects on the Carbohydrate Binding and Selectivity of Flexible Synthetic Carbohydrate Receptors with Indole and Quinoline Heterocyclic Groups.

Authors:  Khushabu Thakur; Milan A Shlain; Mateusz Marianski; Adam B Braunschweig
Journal:  European J Org Chem       Date:  2021-09-12

2.  Evaluation of a Novel Boron-Containing α-D-Mannopyranoside for BNCT.

Authors:  Takao Tsurubuchi; Makoto Shirakawa; Wataru Kurosawa; Kayo Matsumoto; Risa Ubagai; Hiroshi Umishio; Yasuyo Suga; Junko Yamazaki; Akihiro Arakawa; Yutaka Maruyama; Takuya Seki; Yusuke Shibui; Fumiyo Yoshida; Alexander Zaboronok; Minoru Suzuki; Yoshinori Sakurai; Hiroki Tanaka; Kei Nakai; Eiichi Ishikawa; Akira Matsumura
Journal:  Cells       Date:  2020-05-21       Impact factor: 6.600

Review 3.  The yin and yang of imaging tumor associated macrophages with PET and MRI.

Authors:  Sudip Mukherjee; Dominik Sonanini; Andreas Maurer; Heike E Daldrup-Link
Journal:  Theranostics       Date:  2019-10-15       Impact factor: 11.556

Review 4.  Viral Membrane Fusion Proteins and RNA Sorting Mechanisms for the Molecular Delivery by Exosomes.

Authors:  Ilya Zubarev; Dmitry Vladimirtsev; Maria Vorontsova; Igor Blatov; Konstantin Shevchenko; Svetlana Zvereva; Evgenii A Lunev; Evgeny Faizuloev; Nikolay Barlev
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

Review 5.  Molecular imaging of tumor-associated macrophages in cancer immunotherapy.

Authors:  Xiaoying Li; Ruike Wang; Yangnan Zhang; Shuangze Han; Yu Gan; Qi Liang; Xiaoqian Ma; Pengfei Rong; Wei Wang; Wei Li
Journal:  Ther Adv Med Oncol       Date:  2022-02-26       Impact factor: 8.168

6.  Tumor-associated macrophages (TAMs) as biomarkers for gastric cancer: A review.

Authors:  Meri R Räihä; Pauli A Puolakkainen
Journal:  Chronic Dis Transl Med       Date:  2018-09-03

7.  Expression of Narcissus pseudonarcissus lectin and mannose receptor positive macrophages predict progression and prognosis of patients with gastric cancer.

Authors:  Sheng-Sheng Liu; Yi Gao; Shui-Ping Yin; Lei Ye; Zi-Jian Song; Qian Liu; Song-Guo Li; Wei-Dong Du
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.